Siga Technologies vs Tango Therapeutics
Siga Technologies is the larger business, with $94.6m of revenue in fiscal 2025 against $62.4m for Tango Therapeutics (1.5 times as much). Tango Therapeutics grew faster (48.3% against -31.8%). Siga Technologies kept more of each dollar of sales as profit: a net margin of 24.6% against -162.9%.
| Latest fiscal year | Siga TechnologiesSIGA, 2025 | Tango TherapeuticsTNGX, 2025 |
|---|---|---|
| Revenue | $94.6m | $62.4m |
| Revenue growth | -31.8% | 48.3% |
| Net income | $23.3m | −$102m |
| Operating margin | 25.1% | — |
| Net margin | 24.6% | -162.9% |
| Return on equity | 11.2% | -37.2% |
| Free cash flow | $43.1m | −$140m |
| Cash | $155m | $112m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | $0.60 | — |
| Dividend yield | 20.6% | — |
| Share buybacks | $0 | — |
| Employees | 49 | 137 |
| Market value | $222m | $3.95bn |
| Price vs our value range | Below our value range | — |
| Moat score | 71 (Strong) | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 25 sales |